QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
NASDAQ:ITMR

Itamar Medical Stock Forecast, Price & News

$30.34
0.00 (0.00 %)
(As of 10/19/2021 12:00 AM ET)
Add
Compare
Today's Range
$30.26
$30.37
50-Day Range
$16.67
$30.43
52-Week Range
$16.36
$30.50
Volume14,496 shs
Average Volume79,290 shs
Market Capitalization$488.72 million
P/E RatioN/A
Dividend YieldN/A
Beta0.77
30 days | 90 days | 365 days | Advanced Chart
Receive ITMR News and Ratings via Email

Sign-up to receive the latest news and ratings for Itamar Medical and its competitors with MarketBeat's FREE daily newsletter.


Itamar Medical logo

About Itamar Medical

Itamar Medical Ltd. engages in the research, development, marketing, selling, and leasing of non-invasive medical devices based on peripheral arterial tone signals. It develops and markets two products, namely, WatchPAT and EndoPAT. The WatchPAT diagnoses sleep apnea, which has been proven to be a substantial risk factor in cardiac disease. The EndoPAT diagnoses endothelial malfunction, which is a proven predictor of cardiovascular disease. The company was founded by Yaron Giora , Martin Gerstel, Peretz Lavie, and Daniel Gur on January 15, 1997 and is headquartered in Caesarea, Israel.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
N/A
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ITMR
Employees
257
Year Founded
N/A

Sales & Book Value

Annual Sales
$41.03 million

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$488.72 million
Next Earnings Date
11/16/2021 (Estimated)
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.53 out of 5 stars

Medical Sector

1031st out of 1,361 stocks

Analyst Opinion: 2.1Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.6 5 -4 -3 -2 -1 -












Itamar Medical (NASDAQ:ITMR) Frequently Asked Questions

Is Itamar Medical a buy right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Itamar Medical in the last year. There are currently 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Itamar Medical stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ITMR, but not buy additional shares or sell existing shares.
View analyst ratings for Itamar Medical
or view top-rated stocks.

What stocks does MarketBeat like better than Itamar Medical?

Wall Street analysts have given Itamar Medical a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Itamar Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Itamar Medical?

Itamar Medical saw a decrease in short interest during the month of September. As of September 30th, there was short interest totaling 11,000 shares, a decrease of 92.4% from the September 15th total of 145,000 shares. Based on an average trading volume of 160,600 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.1% of the shares of the company are short sold.
View Itamar Medical's Short Interest
.

When is Itamar Medical's next earnings date?

Itamar Medical is scheduled to release its next quarterly earnings announcement on Tuesday, November 16th 2021.
View our earnings forecast for Itamar Medical
.

How were Itamar Medical's earnings last quarter?

Itamar Medical Ltd. (NASDAQ:ITMR) posted its quarterly earnings results on Tuesday, August, 31st. The company reported ($0.29) earnings per share for the quarter, missing analysts' consensus estimates of ($0.27) by $0.02.
View Itamar Medical's earnings history
.

How has Itamar Medical's stock been impacted by Coronavirus (COVID-19)?

Itamar Medical's stock was trading at $11.11 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ITMR stock has increased by 173.1% and is now trading at $30.34.
View which stocks have been most impacted by COVID-19
.

What guidance has Itamar Medical issued on next quarter's earnings?

Itamar Medical updated its FY 2021 earnings guidance on Tuesday, September, 7th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $53 million-$54 million, compared to the consensus revenue estimate of $52.70 million.

What price target have analysts set for ITMR?

6 Wall Street analysts have issued 1 year price targets for Itamar Medical's shares. Their forecasts range from $30.00 to $33.85. On average, they expect Itamar Medical's stock price to reach $31.37 in the next year. This suggests a possible upside of 3.4% from the stock's current price.
View analysts' price targets for Itamar Medical
or view top-rated stocks among Wall Street analysts.

Who are Itamar Medical's key executives?

Itamar Medical's management team includes the following people:
  • Gilad Glick, President, CEO & VP-Sales & Marketing
  • Shy Basson, Chief Financial Officer
  • Efrat Litman, Vice President-Advanced Research & Development
  • Jennifer Cook, Global Medical Director
  • Eilon Livne, VP-Sales & Channels Development

What other stocks do shareholders of Itamar Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Itamar Medical investors own include Gilead Sciences (GILD), AbbVie (ABBV), Carnival Co. & (CCL), Energy Transfer (ET), KeyCorp (KEY), Occidental Petroleum (OXY), Pfizer (PFE), (PRMW), Wells Fargo & Company (WFC) and Abbott Laboratories (ABT).

What is Itamar Medical's stock symbol?

Itamar Medical trades on the NASDAQ under the ticker symbol "ITMR."

How do I buy shares of Itamar Medical?

Shares of ITMR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Itamar Medical's stock price today?

One share of ITMR stock can currently be purchased for approximately $30.34.

How much money does Itamar Medical make?

Itamar Medical has a market capitalization of $488.72 million and generates $41.03 million in revenue each year.

How many employees does Itamar Medical have?

Itamar Medical employs 257 workers across the globe.

What is Itamar Medical's official website?

The official website for Itamar Medical is www.itamar-medical.com.

How can I contact Itamar Medical?

The company can be reached via phone at (724) 617-7000.


This page was last updated on 10/19/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.